Fundraising Fox
/Companies
Sign in

Chrono Therapeutics

Hayward, US · California corporation · 9 known investors

Find your way into Chrono Therapeutics

Sign up to see every warm intro you have to Chrono Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Chrono Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Healthtech

Founders & leadership

GDGUY DIPIERRO
GUY DIPIERROFounder, Chief Business Officer, VP of Intellectual Property/Gov't Affairs2014–2017Chief Operating Officer & Co-Founder at Indapta Therapeutics
AL
ALAN LEVY, PH.D.Executive
AR
ANTHONY RIMACExecutive
AL
ALAN LEVYExecutive

Board

ER
ELIZABETH ROCKETTBoard directorInvestor at Kaiser Permanente Ventures
WHWENDE HUTTON
WENDE HUTTONBoard directorGeneral Partner at Canaan Partners
AKAIDAN KING
AIDAN KINGBoard directorManaging Partner and Co-Founder at Fountain Healthcare Partners
SJ
STEVEN JAMESBoard director
JW
JAMES W. YOUNGBoard director
TK
TIM KILGALLONBoard director

Investors · 9

Emergent Medical Partners, LLPlisted by Emergent Medical Partners, LLPSan Jose

How we know: Emergent Medical Partners, LLP's portfolio page · Not right? Tell us

Fountain Healthcare Partnerslisted by Fountain Healthcare PartnersDublin · $10.8M – $16.2M

How we know: Fountain Healthcare Partners's portfolio page · funding news · techcrunch.com · Not right? Tell us

Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M

How we know: Kaiser Permanente Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us

Mission Bay Capitallisted by Mission Bay CapitalSan Francisco
5AM VenturesreportedSan Francisco · $100K – $4M

How we know: funding news · techcrunch.com · Not right? Tell us

Canaan PartnersreportedStamford · $500K – $20Mvia Wende Hutton · board

How we know: a partner's Signal profile · board seat on SEC Form D · funding news · techcrunch.com · Not right? Tell us

GE VenturesreportedCincinnati

How we know: funding news · techcrunch.com · Not right? Tell us

Mayo Clinic VenturesreportedRochester

How we know: techcrunch.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$51.4M disclosed across 3 rounds · 2014–2016

▶$37.6MraisedSep 2016 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVEN JAMESDirector
  • ALAN LEVY, PH.D.Executive Officer, Director
  • GUY DIPIERRODirector
  • JAMES W. YOUNGDirector
  • ELIZABETH ROCKETTDirector
  • TIM KILGALLONDirector
  • WENDE HUTTONDirector
  • AIDAN KINGDirector
  • ANTHONY RIMACExecutive Officer
Offering amount
$47.6M
Amount sold
$37.6M
First sale
Aug 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.3MraisedJun 2014 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES W. YOUNGDirector
  • TIM KILGALLONDirector
  • ALAN LEVYExecutive Officer, Director
  • GUY DIPIERROExecutive Officer, Director
  • WENDE HUTTONDirector
Offering amount
$33.2M
Amount sold
$13.3M
Placement agents
Leerink Partners LLC
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN LEVYExecutive Officer, Director
  • GUY DIPIERROExecutive Officer, Director
Offering amount
$1M
Amount sold
$500K
Minimum investment
$50K
First sale
Feb 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Chrono Therapeutics went on to found or lead other companies.

Julie GrantBoard ObserverFounded Day One BiopharmaceuticalsGuy DiPierroDirectorFounded Indapta Therapeutics

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$155.3K
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.8M
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$2.2M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Wearable Maker Chrono Raises $32 Million So Smokers Can Kick The Habit | TechCrunchtechcrunch.com · Jun 2014

Frequently asked questions

Who founded Chrono Therapeutics?
Chrono Therapeutics was founded by GUY DIPIERRO.
Who are Chrono Therapeutics's investors?
Chrono Therapeutics's investors include Cota Capital, Emergent Medical Partners, LLP, Fountain Healthcare Partners, Kaiser Permanente Ventures, Mission Bay Capital, 5AM Ventures, Canaan Partners, GE Ventures and 1 more.
How much funding has Chrono Therapeutics raised?
Chrono Therapeutics has disclosed $51.4M raised across 3 rounds.
Where is Chrono Therapeutics headquartered?
Chrono Therapeutics is headquartered in Hayward, US.